baber/WOPTO huggingface dataset:
Patent NZ-545068-A (NZ)
Title: Parasiticidal composition
Inventor: DOKIC-GALLAGHER JASMINA
IPC: A61K31/736
Filed: 2004-07-29
Abstract: Disclosed is a pediculicidal composition, for use in the treatment of lice infestation, comprising, an active ingredient selected from a bioadhesive polymer and pharmaceutically acceptable salts thereof, and a physiologically acceptable carrier; wherein, the physiologically acceptable carrier is a combination of an alcohol and a silicone based compound, and the alcohol is chosen from the group comprising: isopropanol, ethanol and industrial methylated spirit.
Patent NZ-550028-A (NZ)
Title: Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
Inventor: ZELDIS JEROME B
IPC: A61K45/06
Filed: 2004-09-03
Abstract: Disclosed is the use of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof in the preparation of a medicament for treating, managing or preventing a central nervous system disorder, such as Parkinson disease, Alzheimer disease, mild cognitive impairment, Huntington disease, Amytophic Lateral Sclerosis, depression and defective long-term memory, and related syndromes.
Patent NZ-555091-A (NZ)
Title: Key for a cylinder lock
Inventor: NEUMAYER HARALD
Filed: 2007-05-10
Abstract: A key for a cylinder lock, in particular lock systems, is disclosed. The key has defining lateral surfaces with longitudinal grooves provided. The arrangement and cross-section of these grooves can be varied. At least one of these grooves has a cross-section which corresponds to a basic triangle which defines a basic flank. Two groove flanks 8 and 9 extend from the basic flank up to an intersection line, whilst one of the groove flanks may also form the bisector of the basic triangle, so that two deep versions of grooves can be arranged in the basic triangle. At least one shallow groove version is formed in which one of the groove flanks is half the length of the flank of the other groove flank that extends from the flat side of the key 1 up to an intersection line 10.
Patent NZ-561905-A (NZ)
Title: Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: PEGLION JEAN-LOUIS
Filed: 2007-09-25
Abstract: Disclosed are compounds of formula I, of trans configuration, wherein X represents oxygen or NR2, Y represents a group selected from -CH2-, -(CH2)2- and -CH=CH-, and R1 and R2, which may be the same or different, each represents a hydrogen atom or a group selected from linear or branched C1-C6alkyl, C3-C8cycloalkyl, and cycloalkylalkyl wherein the alkyl moiety is C1-C6 and is linear or branched and the cycloalkyl moiety is C3-C8, in racemic form or in the form of optical isomers, and also addition salts thereof with a pharmaceutically acceptable acid, and hydrates thereof. Also disclosed are processes for their preparation. The compounds are useful in the treatment of disorders of the central nervous system that involve the dopaminergic system, such as neuroprotection or treatment of neurodegenerative disorders, hyperprolactinaemia, sexual dysfunction, depression or anxiety, Parkinson's disease, Alzheimer's disease and cerebral attacks.
Patent NZ-569272-A (NZ)
Title: Tracing items through a non-sequential process
Inventor: THORSSON BRYNJOLFUR
IPC: A22B5/00
Filed: 2006-12-19
Abstract: A system for tracing items through a non-sequential process is disclosed. The system comprises at least one in-feed area, and at least one out-feed area, a human machine interface, at least one processing means, means for selecting at least one processing station to process an item (13), means for transferring the item between the at least one processing station, while tracing its position, means for processing the item into smaller objects, means for transferring the smaller objects to an out-feed area, while tracing their position, a control means, a data storage and retrieving means for storing first tracing information relating to the items arriving at the in-feed location and second tracing information relating to the handling of the items and computing means. At the out-feed area each of the smaller objects is provided with at least one information record related to the item and the processing thereof. The control means interacts with the transfer means to perform a non-sequential transport of the items from the at least one in-feed location to the at least one out-feed location. The computing means processes information and the data storage means stores the first tracing information relating to the items at the in-feed location and the second tracing information relating to the items after handling as historic information of the items. The information record constitutes traceable historic information of the smaller objects. The information record is generated from the first tracing information, the processing information, and the second tracing information, and the first tracing information and second tracing information is obtained with imaging means. The non-sequential transport of the smaller objects is carried out by a robot.
Patent NZ-574964-A (NZ)
Title: Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
Inventor: BELL ROBERT G
IPC: A61K/
Filed: 2004-07-16
Abstract: Provided is the use of estrogen and progestin in the manufacture of a medicament for increasing contraceptive effectiveness in a higher weight female in need thereof, wherein the medicament is formulated into dosage forms of (a) 21 dosage forms comprising estrogen and progestin; and (b) 7 dosage forms consisting essentially of estrogen; wherein the estrogen in (a) is present in a daily amount equivalent to 20 micrograms of ethinyl estradiol; wherein the progestin in (a) is present in a daily amount equivalent to 150 micrograms of desogestrel; wherein the estrogen in (b) is present in a daily amount equivalent to 10 micrograms of ethinyl estradiol; wherein each of the 21 dosage forms in (a) is formulated for administration sequentially and continuously each day for 21 consecutive days and wherein each of the 7 dosage forms in (b) is formulated for administration sequentially and continuously each day for 7 consecutive days following the 21 dosage forms; and wherein the higher weight female has a body mass index of greater than 25.
Patent NZ-575651-A (NZ)
Title: Avian-based insect repellent isolated from parrots (Cacatua)
Inventor: CHAMBERLAIN JOHN
IPC: A01N63/10
Filed: 2007-08-17
Abstract: Disclosed is a fly, tick and lice repellent comprising an extract isolated from the feathers of an Australian native parrot obtained by treating the feathers with an organic solvent.
Patent NZ-576274-A (NZ)
Title: Compositions and methods for suppressing endometrial proliferation
Inventor: PODOLSKI JOSEPH S
IPC: C07J41/00
Filed: 2007-10-24
Abstract: Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/or pain associated therewith in a female in need thereof wherein the medicament is formulated for use in a dosage regimen comprising the steps of; (a) the medicament is administered for an administration period during which the medicament is administered at one or more intervals of N weeks or less; thereafter (b) temporarily discontinuing the administration of step (a) for a discontinuation period of more than N weeks; and thereafter (c) repeating steps (a) and (b) at least once, wherein N is 1, 2, 3, or 4, and wherein said female undergoes menstruation during at least one discontinuation period and with the proviso that none of the following agents is administered during step (a) or step (b): a GnRH agonist, a GnRH antagonist and an estrogen.
Patent NZ-580243-A (NZ)
Title: Authenticating and verifying a human identity using a light reflectance spectrum of a fingertip or iris
Inventor: PISHVA DAVAR
IPC: G06K9/00
Filed: 2007-05-08
Abstract: A multifactor authentication system is disclosed. The system comprises a sheet prism or other prism means, a light source, a non-spectrometric biometric signature acquisition means, a spectral information acquisition means and an identity determination and verification means. The non-spectrometric biometric signature acquisition means acquires a fingerprint image of a fingertip of a person to be authenticated. This means comprises a CCD or CMOS sensor and a first optical system, which in turn comprises at least a first lens and forms fingerprint image on the CCD or CMOS sensor. The spectral information means acquires a diffuse reflectance spectrum of the fingertip. This means comprises a photodiode array (PDA) and a second optical system, which in turn comprises at least a second lens and a diffraction grating and disperses the reflected light from the fingertip onto the PDA. The identity determination and verification means comprises a computer or other information processing means ad uses the fingerprint to determine the unique identity of the person to be authenticated. This means uses the diffuse reflectance spectrum of the fingertip to verify that the person to be authenticated is a living human being with predetermined spectral characteristics. In use, the fingertip is placed on the sheet prism or other prism means. The light from the light source is made incident on the fingertip via the sheet prism or other prism means. The first optical system forms an image of the spectrally reflected light from the fingertip on the CCS or CMOS sensor and at the same time the second optical system spectrally disperses the diffusely reflected light from the fingertip onto the PDA. This enables the fingerprint image and the diffuse reflectance spectrum of the fingertip to be acquired simultaneously.
Patent NZ-581196-A (NZ)
Title: Gel humidifier with semi-permeable membrane for use with tobacco products
Inventor: SUTTON JOSEPH PETER
IPC: A24F25/02
Filed: 2008-05-29
Abstract: A humidifier (10) for use with tobacco products comprises a gel body (12) comprising a continuous porous network of particles supporting a volume of moisturising liquid, the gel body configured to release the liquid by evaporation at a predetermined rate, and a permeable layer (14) enclosing the gel body through which the evaporated liquid may pass. The permeable layer comprises a semi-permeable one-way membrane (18) that transmits evaporated liquid from the gel body but substantially blocks the passage of water vapour or liquid to the gel body. Examples of useful gels include alginates and pectins. Additional modifying substances such as salts can also be included for further tailoring of the evaporation rate.
Patent NZ-583203-A (NZ)
Title: Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
Inventor: KAWASAKI JUNICHI
IPC: A61K9/48
Filed: 2008-07-16
Abstract: Disclosed is a composition comprising: i. an 11-deoxy-prostaglandin compound represent by general formula (II), and ii. a fatty acid ester obtained from a fatty acid having C6-24 carbon atoms, such as capric, lauric or oleic acid, and an alcohol selected from the group consisting of C1-6 monovalent alcohol, glycerine and propylene glycol. Also disclosed is a method for stabilizing an 11-deoxy-prostaglandin compound of formula (II) comprising mixing the 11-deoxy-prostaglandin compound with a fatty acid ester obtained from a fatty acid having C6-24 carbon atoms and an alcohol selected from the group consisting of C1-6 monovalent alcohol, glycerine and propylene glycol.
Patent NZ-586815-A (NZ)
Title: Hydraulic driven turning device with piston acting on spiral part to cause rotation
Inventor: RAUNISTO YRJO
IPC: F15B15/06
Filed: 2009-02-09
Abstract: A hydraulic driven turning device to be installed to a construction machine is disclosed. The turning device includes a first body (1) and a second body (6) capable of turning in relation to the first body (1). A hydraulic cylinder is defined by or attached to the first and second bodies and a piston (5) located within the cylinder can be moved axially back and forth with the help of a hydraulic pressure medium. A spiral part (2) is attached to the piston, the spiral part (2) causes a rotational movement to a counterpart (3) also equipped with a spiral. The rotational movement is transferred to a turning movement of the second body (6) relative to the first body (1). The device is characterized in that the piston (5) is arranged to be non-rotating in the cylinder through the engagement of the contacting walls of the piston and cylinder. The non-rotation is achieved by forming the cross section of the piston (5) and the cylinder to be deviant from a round form, such as oval or angular, or by adjusting the piston (5) to be eccentric in relation to its bearing axle.
Patent NZ-592214-A (NZ)
Title: Improved Interleukin-6 receptor antibody molecule
Inventor: IGAWA TOMOYUKI
IPC: A61K39/395
Filed: 2009-09-25
Abstract: Disclosed is an Interlukin-6 antibody which comprises a heavy chain variable region that comprises CDR1 comprising the sequence of SEQ ID NO: 4, CDR2 comprising the sequence of SEQ ID NO: 5, and CDR3 5 comprising the sequence of SEQ ID NO: 6, and a light chain variable region that comprises CDR1 comprising the sequence of SEQ ID NO: 13, CDR2 comprising the sequence of SEQ ID NO: 14, and CDR3 comprising the sequence of SEQ ID NO: 15.
Patent NZ-593391-A (NZ)
Title: Effluent treatment and compositions therefor
Inventor: CALVERT KENNETH CHARLES
IPC: B65F5/00
Filed: 2011-06-10
Abstract: 593391 Disclosed is the use of (a) lignite ash or (b) lignite ash and one or more magnesium salts to coagulate and/or precipitate solids from effluent. A method of treating effluent, the method comprising providing an effluent comprising a liquid component and optionally comprising retainable solids contacting the effluent with (a) lignite ash or (b) lignite ash and one or more magnesium salts to coagulate and/or precipitate retainable solids in the effluent, and separating the retainable solids and the liquid component. The lignite ash comprises both bottom ash and fly ash.
Patent NZ-594682-A (NZ)
Title: Fully human antibodies specific to cadm1
Inventor: TERRETT JONATHAN ALEXANDER
IPC: A61K33/243
Filed: 2010-03-05
Abstract: 594682 FULLY HUMAN ANTIBODIES SPECIFIC TO CADM1 Provided is an isolated monoclonal antibody, or an antigen-binding portion thereof or an antibody fragment thereof, which binds human CADM1 and which comprises: specified sequences of the heavy chain and the light chain variable regions amino acid sequences having at least 85% sequence identity thereto. The antibodies can be used to treat various cancers.
Patent NZ-596074-A (NZ)
Title: Process for preparation of HIV protease inhibitors via bisfuran intermediates
Inventor: CRAWFORD KENNETH R
IPC: C07C327/42
Filed: 2007-03-29
Abstract: 596074 The disclosure relates generally to processes for the preparation of antiviral compounds with anti-HIV protease properties. The disclosure relates to the methods for the preparation of carbamate sulfonamide amino phosphonate esters and intermediates thereof. The disclosure also relates to the novel intermediates prepared by these methods. The carbamate sulfonamide amino phosphonate esters prepared by the present methods are HIV protease inhibitors, useful for the treatment of human auto immunodeficiency syndrome (AIDS).
Patent NZ-596968-A (NZ)
Title: Detection of collisions of radio coverage cell identifiers
Inventor: LARSSON DANIEL
IPC: H04W24/10
Filed: 2009-12-29
Abstract: Disclosed is a method for use in a radio communications system including multiple radio base stations and multiple radio terminals. The method includes determining a first positioning reference signal for a first cell associated with a first radio base station that is based on a first identifier associated with the first cell and determining a second positioning reference signal for a second cell associated with a second radio base station that is based on a second identifier associated with the second cell. A radio terminal is capable of detecting the first and second positioning reference signals. Information is obtained in a positioning reference signal that the first and second base stations transmitted a same cell identifier and different positioning reference signals. Based on that obtained information, a collision is determined between the first and second cell identifiers. The collision is then resolved by associating a different, non-conflicting cell identifier to either of the first cell or the second cell.
Patent NZ-597190-A (NZ)
Title: Subcutaneous anti-her2 antibody formulation
Inventor: ADLER MICHAEL
IPC: A61K9/00
Filed: 2010-07-28
Abstract: Disclosed is a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody for subcutaneous injection comprising: a. about 50 to 350 mgl/ml anti-HER2 antibody; b. about 1 to 100 mM of a buffering agent providing a pH of 5.5 +- 2.0; c. about 1 to 500 mM of a stabilizer or a mixture of two or more stabilizers; d. about 0.01 to 0.08 % of a nonionic surfactant and e. from >150 to about 16,000 U/ml of a hyaluronidase enzyme.
Patent NZ-599312-A (NZ)
Title: Plant disease controlling composition and method for controlling plant disease
Inventor: SOMA MASATO
IPC: A01N37/18
Filed: 2009-03-24
Abstract: Disclosed is a plant disease controlling composition comprising, as active ingredients: A pyrazolonyl-containing compound of formula (I), and at least one compound selected from the group consisting of a compound selected from the group consisting of a compound formula IIa and IIb or their agrochemically acceptable salts. Compounds of formula IIa and IIb appear to be related to the strobilurin class of pesticides. Also disclosed is a method for controlling a plant disease comprising applying the composition to plants, seeds or cropland.
Patent NZ-621439-A (NZ)
Title: Vaccine
Inventor: BRUNNER SYLVIA
IPC: C12N9/64
Filed: 2012-09-13
Abstract: Disclosed is a vaccine comprising at least two fragments of Proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein at least one fragment of said at least two fragments comprises at least 8 consecutive amino acid residues of amino acid residues 150 to 170 of PCSK9 according to SEQ ID No. 9 and wherein at least one fragment of said at least two fragments comprises at least 8 consecutive amino acid residues 205 to 225 of PCSK9 according to SEQ ID No. 9, wherein SEQ ID NOs: 8 and 9 are disclosed within the specification.
Patent NZ-624272-A (NZ)
Title: C7-fluoro substituted tetracycline compounds
Inventor: XIAO XIAO-YI
IPC: C07D209/52
Filed: 2009-08-07
Abstract: The disclosure relates to a C7-fluoro substituted tetracycline compound of structural formula (II), compositions comprising said compound and uses thereof, wherein the variables are as defined in the specification. These compound are useful as anti-microbial agent and is therefore useful in the treatment or prevention of infections caused by a bacteria, particularly by a Gram-positive bacterium selected from Staphylococcus spp., Streptococcus spp., Propionibacterium .Ipp., Enterococcus spp., Bacillus spp., Corynebacterium spp., Nocardia spp., Clostridium spp., Actinobacteria spp., and Listeria spp.. or by a Gram-negative bacterium selected from Enterobactericeae, Bacteroidaceae, Vibrionaceae , Pasteurellae, Pseudomonadaceae, Neisseriaceae, Rickettsiae, Moraxellaceae, any speCIes of Proteeae, Acinetobacter spp., Helicobacter spp., and Campylobacter spp ., wherein the infection is a skin infection, a respiratory tract infection, a hospital acquired infection, an intra-abdominal infection or a urinary tract infection.
Patent NZ-625385-A (NZ)
Title: Intelligent infrastructure management user device
Inventor: POLLAND JOSEPH
IPC: H04L29/02
Filed: 2012-11-21
Abstract: An infrastructure management device is disclosed. The infrastructure management device comprises a processor configured to obtain port status and networking device status for each of one or more physical networking devices in a system. The device also comprises a display unit coupled to the processor and configured to display one or more virtual networking devices, and a user input element configured to provide user input to the processor. The port status indicates that a cable is inserted into the first port and the processor obtains cable data identifying one or more characteristics of the cable inserted into the first port. The processor is configured to compare the one or more characteristics of the cable inserted into the first port with one or more characteristics defined in the work order. The processor is configured to provide a notification to a user indicating whether the one or more characteristics of the inserted cable comply with the work order.
Patent NZ-631020-A (NZ)
Title: Oro-nasal patient interface
Inventor: BARLOW ADAM FRANCIS
IPC: A61M16/08
Filed: 2014-05-14
Abstract: Disclosed is a CPAP patient respiratory interface for sleep apnoea to provide breathable gas or air to a patient with an improved fit to the patient’s face. The interface comprises a plenum chamber assembly, comprising a nasal plenum chamber at least partly defining a first gas chamber, the nasal plenum chamber structured to contact the patient’s nose below the bridge of the nose and around the lower periphery of the nose. An oral plenum chamber at least partly defines a second gas chamber, the oral plenum chamber structured to seal around the patient’s mouth. A decoupling structure at least partly connects the nasal plenum chamber and the oral plenum chamber and at least partly defines a flow path between the nasal plenum chamber and the oral plenum chamber. The decoupling structure is configured to decouple relative movement between the nasal plenum chamber and the oral plenum chamber. A top plate is operatively connected to the plenum chamber assembly at the nasal plenum chamber, including at least one connection feature configured to releasably retain a first portion of a positioning and stabilising structure. A faceplate is operatively connected to the plenum chamber assembly at the oral plenum chamber, and configured to releasably retain a second portion of the positioning and stabilising structure, where the top plate and faceplate are more rigid than the plenum chamber assembly.
Patent NZ-718465-A (NZ)
Title: Odour trap with check valve and air admittance valve
Inventor: MCALPINE JAMES EDWARD
IPC: E03C1/288
Filed: 2014-09-22
Abstract: A trap for a waste outlet for use in drainage facilities is described which provides a water seal. The trap comprises a one-way valve (23) at the trap inlet (14) and a pressure one-way valve (24) at the trap outlet (16) such that, in addition to prevent ingress of animals from the soil pipe to the buildings, prevents ingress of odours and the water seal being sucked away. The pressure valve (24) allows in the presence of a negative pressure differential across the outlet one-way pressure valve that air can pass through the pressure valve (24) to relieve the pressure differential but in the event of a positive pressure differential, air is prevented from passing through the oneway pressure valve (24).
Patent NZ-718688-A (NZ)
Title: Adam6 mice
Inventor: MACDONALD LYNN
IPC: C12N15/85
Filed: 2012-02-24
Abstract: Discloses a rodent that has undergone immunoglobulin gene sequence rearrangement so that it comprises a B cell that includes in its genome: (i) a rearranged human heavy chain variable region sequence operably linked to a rodent heavy chain constant region sequence, wherein the rearranged human heavy chain variable region sequence comprises a human VH gene segment, a human DH gene segment, and/or a human JH gene segment; and (ii) an inserted nucleic acid sequence encoding an ADAM6 protein on the same chromosome as the rearranged immunoglobulin sequence, wherein the ADAM6 protein is expressed from the nucleic acid sequence. Further discloses methods of generating antibodies using cells of said CDJ recombinant ADAM6 rodent.